Switch theme
Sign up to access all valuation multiples
Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.
1997
165
LTM Revenue $31.0M
LTM EBITDA $5.7M
$179M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Carasent has a last 12-month revenue (LTM) of $31.0M and a last 12-month EBITDA of $5.7M.
In the most recent fiscal year, Carasent achieved revenue of $28.4M and an EBITDA of $1.8M.
Carasent expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carasent valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $31.0M | XXX | $28.4M | XXX | XXX | XXX |
| Gross Profit | $26.1M | XXX | $24.0M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 85% | XXX | XXX | XXX |
| EBITDA | $5.7M | XXX | $1.8M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 6% | XXX | XXX | XXX |
| EBIT | -$1.6M | XXX | -$5.1M | XXX | XXX | XXX |
| EBIT Margin | -5% | XXX | -18% | XXX | XXX | XXX |
| Net Profit | -$2.2M | XXX | -$4.4M | XXX | XXX | XXX |
| Net Margin | -7% | XXX | -15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Carasent's stock price is SEK 27 (or $3).
Carasent has current market cap of SEK 1.9B (or $201M), and EV of SEK 1.7B (or $179M).
See Carasent trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $179M | $201M | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Carasent has market cap of $201M and EV of $179M.
Carasent's trades at 6.3x EV/Revenue multiple, and 99.0x EV/EBITDA.
Equity research analysts estimate Carasent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carasent has a P/E ratio of -92.3x.
See valuation multiples for Carasent and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $201M | XXX | $201M | XXX | XXX | XXX |
| EV (current) | $179M | XXX | $179M | XXX | XXX | XXX |
| EV/Revenue | 5.8x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | 31.3x | XXX | 99.0x | XXX | XXX | XXX |
| EV/EBIT | -112.8x | XXX | -35.1x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -92.3x | XXX | -46.1x | XXX | XXX | XXX |
| EV/FCF | -97.2x | XXX | -336.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCarasent's last 12 month revenue growth is 21%
Carasent's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Carasent's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carasent's rule of X is 71% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Carasent and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | 61% | XXX | 416% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 71% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carasent acquired XXX companies to date.
Last acquisition by Carasent was XXXXXXXX, XXXXX XXXXX XXXXXX . Carasent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Carasent founded? | Carasent was founded in 1997. |
| Where is Carasent headquartered? | Carasent is headquartered in Sweden. |
| How many employees does Carasent have? | As of today, Carasent has 165 employees. |
| Is Carasent publicy listed? | Yes, Carasent is a public company listed on STO. |
| What is the stock symbol of Carasent? | Carasent trades under CARA ticker. |
| When did Carasent go public? | Carasent went public in 2012. |
| Who are competitors of Carasent? | Similar companies to Carasent include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Carasent? | Carasent's current market cap is $201M |
| What is the current revenue of Carasent? | Carasent's last 12 months revenue is $31.0M. |
| What is the current revenue growth of Carasent? | Carasent revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Carasent? | Current revenue multiple of Carasent is 5.8x. |
| Is Carasent profitable? | Yes, Carasent is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Carasent? | Carasent's last 12 months EBITDA is $5.7M. |
| What is Carasent's EBITDA margin? | Carasent's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Carasent? | Current EBITDA multiple of Carasent is 31.3x. |
| What is the current FCF of Carasent? | Carasent's last 12 months FCF is -$1.8M. |
| What is Carasent's FCF margin? | Carasent's last 12 months FCF margin is -6%. |
| What is the current EV/FCF multiple of Carasent? | Current FCF multiple of Carasent is -97.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
